 Celldex Therapeutics Inc NASDAQ: CLDX has priced an underwritten public offering of around 5.9 million shares at 42.00 per share, representing a discount of about 6 from the last close price of 44.6 on Tuesday. Gross proceeds are expected to approximately 250 million. 